VANCOUVER, July 17, 2019 /CNW/ - Harvest One Cannabis
Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQX: HRVOF)
today announced that the Company, through its wholly-owned
subsidiary, Satipharm Ltd. ("Satipharm"), has entered into a Supply
Agreement (the "Agreement") with GenCanna Global USA ("GenCanna") dated June 4, 2019. Under the terms of the Agreement,
GenCanna will supply Harvest One with GMP Certified CBD oil and
finished products for distribution in regulated markets in
the United States, Europe, and around the globe, currently under
the Dream Water, Satipharm, and LivRelief™ brands for an initial
term of two years. In addition, GenCanna will support the Company
in the research, development, and formulation of both existing and
new CBD-infused products.
With an industry-leading 38,000+ retail distribution points
around the globe (including, Walmart US, CVS, Kroger, Shoppers Drug
Mart, Loblaw, Holland &
Barrett and Boots), Harvest One is quickly becoming a leading
global house of brands in the health, wellness, and self-care
sectors, with cannabis, cannabis-infused, and all-natural product
offerings. From Satipharm's patented GelPell® CBD capsules, to
Dream Water's all natural, single shot sleep products, and the
recent addition of LivRelief™, Canada's leading all natural topical pain
relief cream, the Agreement with GenCanna ensures the consistent
supply of premium quality hemp-derived CBD for infusion of our
existing products and further product innovation.
"Working with world-class partners like GenCanna to supply
premium quality, traceable, consistent ingredients, all from
GMP-certified facilities, is critical to our core strategy at
Harvest One to only offer consumers best-in-class premium products,
with consistent and predictable effects, in delivery formats they
have come to understand and demand" said Grant Froese, Chief Executive Officer of Harvest
One. Mr. Froese added, "this Agreement signals the beginning of a
global relationship with GenCanna under which we will continue to
innovate, infuse our existing portfolio of products, and bring new
products to market under our well-recognized and trusted,
Satipharm, Dream Water, and LivRelief™ brands".
"Our evolving relationship with Harvest One reflects both
companies' devotion to consumer product quality" said Steve Bevan, Executive Chair of GenCanna. "Joint
research and development have combined to provide excellent CBD
product additions to Harvest One's suite of leading-edge brands. We
expect that consumers will quickly welcome these products on retail
shelves globally" added Steve
Bevan.
Under the terms of the Agreement, GenCanna will provide a
production platform that uses innovative, proprietary harvesting
and crop processing technologies that produce unmatched purity and
quality. This will allow Harvest One and their brands around the
world to access a consistent and fully compliant stable supply of
hemp derived CBD extract and products that consumers and patients
can count on.
About Harvest One Cannabis Inc.
Harvest One is a global consumer packaged goods company that
develops and distributes premium health, wellness, and lifestyle
products to patients and consumers in regulated markets around the
world. The Company's portfolio of premium products is designed to
enhance quality of life. Shareholders have significant exposure to
the entire cannabis value chain through four wholly-owned
subsidiaries: United Greeneries, a Licensed Producer; Satipharm
(medical and nutraceutical); Dream Water Global and Delivra
(consumer products with an emphasis on sleep, pain, and anxiety),
and a minority interest in Burb Cannabis (retail operations). For
more information, please visit www.harvestone.com.
About GenCanna
GenCanna is a vertically-integrated agriculture-technology
company specializing in the production of high quality hemp-derived
CBD. Founded in 2014, as an inaugural member of the Kentucky
Department of Agriculture's Industrial Hemp Pilot Program, the
company is a longstanding industry pioneer. GenCanna works closely
with state universities, consumer protection agencies and other
regulatory bodies driving key industry language and legislation.
Consistent extraction methods and innovative processing
technologies ensure GenCanna production processes exceed all
regulatory standards for FDA registered and inspected food
production facilities (learn more
at https://gencanna.com/compliance/). The GenCanna Production
Platform™ assures standardized, repeatable quality from farm to
finished product.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained in this press release constitute
forward-looking information. These statements relate to future
events or future performance. The use of any of the words "could",
"intend", "expect", "believe", "will", "projected", "estimated" and
similar expressions and statements relating to matters that are not
historical facts are intended to identify forward-looking
information and are based on the Company's current belief or
assumptions as to the outcome and timing of such future
events. Actual future results may differ
materially. The forward-looking information contained in this press
release is made as of the date hereof, and the Company is not
obligated to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise,
except as required by applicable securities laws. Because of the
risks, uncertainties and assumptions contained herein, investors
should not place undue reliance on forward-looking information. The
foregoing statements expressly qualify any forward-looking
information contained herein.
Neither TSX-V nor its Regulation Services Provider (as that
term is defined in the policies of the TSX-V) accept responsibility
for the adequacy or accuracy of this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/harvest-one-signs-supply-agreement-with-gencanna-for-extracted-products-300886514.html
SOURCE Harvest One Cannabis Inc.